{
    "clinical_study": {
        "@rank": "147861", 
        "acronym": "ESS-NSPAS", 
        "arm_group": {
            "arm_group_label": "Essure+NovaSure", 
            "description": "The group of women relying on Essure micro-inserts for permanent birth control when NovaSure is performed following a successful Essure Confirmation Test"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the post approval study is to evaluate the effectiveness and safety of the\n      Essure System when a NovaSure Endometrial Ablation procedure is performed following a\n      successful Essure Confirmation Test."
        }, 
        "brief_title": "Essure-NovaSure Post Approval Study", 
        "completion_date": {
            "#text": "February 2019", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Contraception", 
            "Menorrhagia"
        ], 
        "condition_browse": {
            "mesh_term": "Menorrhagia"
        }, 
        "detailed_description": {
            "textblock": "This study has previously been posted by Conceptus, Inc. After acquiring Conceptus, Inc.,\n      Bayer is now the sponsor of the trial."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All inclusion criteria from the Essure Permanent Birth Control System Instructions\n             for Use and/or the NovaSure Impedance Controlled Endometrial Ablation (EA) System\n             Instructions for Use and Controller Operator's Manual will apply.\n\n          -  Women experiencing menorrhagia due to benign causes\n\n          -  Women who are relying on the Essure micro-inserts for permanent contraception\n             following a successful Essure Confirmation Test (as applicable to the Post Approval\n             Study)\n\n          -  Women willing to accept the risk of pregnancy while relying on the Essure\n             micro-inserts for prevention of pregnancy following a NovaSure ablation procedure for\n             menorrhagia\n\n        Exclusion Criteria:\n\n          -  All exclusion criteria from the Essure Permanent Birth Control System Instructions\n             for Use and/or the NovaSure Impedance Controlled Endometrial Ablation System\n             Instructions for Use and Controller Operator's Manual will apply.\n\n          -  Women who previously underwent a fallopian tube sterilization procedure (other than\n             Essure placement)\n\n          -  Women who present with any other medical complaints, conditions or symptoms unrelated\n             to the Essure System and/or subsequent NovaSure EA including, but not limited to:\n\n               -  Gynecological co-morbidities (e.g., pelvic infection, cervicitis, undiagnosed\n                  vaginal bleeding, endometrial cancer, myomas, and polyps)\n\n               -  Reproductive tract anatomical variants and/or pathology which could make the\n                  subject unsuitable for the Essure and/or NovaSure transcervical procedures\n\n          -  Women currently wearing an intrauterine device"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "21 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects who have been identified as candidates for NovaSure Endometrial Ablation and have\n        been/will be relying on Essure micro-inserts for permanent contraception (following a\n        successful Essure Confirmation Test)."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01740687", 
            "org_study_id": "16975", 
            "secondary_id": "ESS-NSPAS"
        }, 
        "intervention": [
            {
                "arm_group_label": "Essure+NovaSure", 
                "description": "Essure Permanent Birth Control", 
                "intervention_name": "ESS305 (Essure, BAY1454032)", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Essure+NovaSure", 
                "description": "Nova Sure Endometrial Ablation", 
                "intervention_name": "NovaSure", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Endometrial Ablation", 
            "Permanent Sterilization", 
            "Essure", 
            "NovaSure", 
            "Prevention of Pregnancy"
        ], 
        "lastchanged_date": "May 9, 2014", 
        "link": [
            {
                "description": "Click here and search for drug information provided by the FDA.", 
                "url": "http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm"
            }, 
            {
                "description": "Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.", 
                "url": "http://www.fda.gov/medwatch/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85015"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80220"
                    }
                }, 
                "status": "Terminated"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Decatur", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "62526"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Wayne", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46825"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newburgh", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "47630"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Easton", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21601"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grand Blanc", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48439"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27103"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43214"
                    }
                }, 
                "status": "Terminated"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pottstown", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19464"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37205"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spokane", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "99202-1334"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test", 
        "overall_contact": {
            "email": "clinical-trials-contact@bayerhealthcare.com", 
            "last_name": "Bayer Clinical Trials Contact"
        }, 
        "overall_contact_backup": {
            "last_name": "For trial location information (Phone Menu Options '3' or '4')", 
            "phone": "(+)1-888-84 22937"
        }, 
        "overall_official": {
            "affiliation": "Bayer", 
            "last_name": "Bayer Study Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "1-Year Pregnancy Rate", 
                "safety_issue": "No", 
                "time_frame": "1 year after NovaSure Endometrial Ablation procedure"
            }, 
            {
                "measure": "3-Year Pregnancy Rate", 
                "safety_issue": "No", 
                "time_frame": "3 years after NovaSure Endometrial Ablation procedure"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01740687"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Number of participants with adverse events as a measure of safety", 
            "safety_issue": "Yes", 
            "time_frame": "Up to 3 years"
        }, 
        "source": "Bayer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bayer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}